• Explore /
  • Poster
  • / Phase I/II trial of cetuximab with 5-fluorouracil and mitomycin C concurrent with radiotherapy in patients with muscle invasive bladder cancer.

Phase I/II trial of cetuximab with 5-fluorouracil and mitomycin C concurrent with radiotherapy in patients with muscle invasive bladder cancer.

Abstract Poster

Authors

Syed Hussain

Syed A. Hussain

University of Liverpool, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom

Syed A. Hussain , Laura Buckley , Baljit Kaur , Carey Hendron , Anjali Zarkar , Daniel Ford , Richard Viney , Isabel Syndikus , Zafar Malik , Chinnamani Eswar , Amisha Desai , Elizabeth Southgate , Stephen Mangar , Johannes Van Der Voet , Anna Lydon , Nicholas D. James

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

ISRCTN80733590

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4527)

DOI

10.1200/JCO.2017.35.15_suppl.4527

Abstract #

4527

Poster Bd #

205

Abstract Disclosures

Similar Posters

First Author: Nicholas D. James

First Author: Syed A. Hussain

First Author: Sebastian Stintzing

First Author: Signe Friesland